PSIP1P1

Across TCGA pan-cancer cohorts, PSIP1P1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated PSIP1P1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher PSIP1P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated PSIP1P1 expression acts as an unfavorable survival marker, although some lineages such as READ and KIRC show a favorable association.

READ, LIHC, and KIRC are the cancer types where PSIP1P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.751	0.364	.001	55	view →
LIHC	OS	Tertile	II,III,IV	0.512	0.772	<.001	48	view →
KIRC	DFS	Tertile	All	0.754	0.479	<.001	41	view →
ACC	OS	Median	All	0.465	0.754	.003	41	view →
KICH	DFS	Median	III,IV	0.275	0.861	.002	40	view →
UCEC	OS	Tertile	All	0.894	0.946	.002	38	view →
MESO	DFS	Median	IV	0.211	0.466	.015	33	view →
UCS	DFS	Tertile	IV	0.981	0.401	.024	30	view →
LUSC	OS	Quartile	All	0.863	0.749	.001	27	view →
CESC	OS	Tertile	II,III,IV	0.900	0.670	.007	26	view →
CHOL	DFS	Quartile	II,III,IV	1.000	0.135	.005	25	view →
LUAD	DFS	Median	IV	0.777	0.212	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

PSIP1P1–READ (DFS)

Open the READ breakdown →